Evidence map›Paper›PMID 28928879›Full record

ArticleJournal of Cancer2017

Usama Salem, Behrang Amini, Hubert H Chuang, Najat C Daw, Wei Wei, Tamara Miner Haygood, John E Madewell, Colleen M Costelloe

Abstract read
In one paragraph

Article in Journal of Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. [European radiology · 2021
    Article
  9. Article
  10. Article
  11. The British journal of radiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Usama SalemDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Behrang AminiDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Hubert H ChuangDepartment of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.
Najat C DawDepartment of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Wei WeiDepartment of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Tamara Miner HaygoodDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
John E MadewellDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Colleen M CostelloeDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ewing sarcomaFDG PET/CTOverall survivalProgression free survival.SUV

Identifiers

PMID28928879
PMCPMC5604439

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.